首页> 美国卫生研究院文献>Molecular Human Reproduction >Peroxisome-proliferator activator receptor-gamma activation decreases attachment of endometrial cells to peritoneal mesothelial cells in an in vitro model of the early endometriotic lesion
【2h】

Peroxisome-proliferator activator receptor-gamma activation decreases attachment of endometrial cells to peritoneal mesothelial cells in an in vitro model of the early endometriotic lesion

机译:在早期子宫内膜异位病变模型中过氧化物酶体增殖物激活剂受体-γ激活减少了子宫内膜细胞对腹膜间皮细胞的附着

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study was to investigate whether peroxisome proliferator-activated receptor (PPAR)-γ activation has an effect on the attachment of endometrial cells to peritoneal mesothelial cells in a well-established in vitro model of the early endometriotic lesion. The endometrial epithelial cell line EM42 and mesothelial cell line LP9 were used for this study. EM42 cells, LP9 cells or both were treated with the PPAR-γ agonist ciglitazone (CTZ) at varying concentrations (10, 20 and 40 µM) × 48 h with subsequent co-culture of EM42 and LP9 cells. The rate of EM42 attachment and invasion through LP9 cells was then assessed and compared with control (EM42 and LP9 cells co-cultured without prior treatment with CTZ). Next, attachment of CTZ-treated and untreated EM42 cells to hyaluronic acid (HA), a cell adhesion molecule (CAM) on peritoneal mesothelial cells, were assessed. Although there was no difference in EM42 attachment when LP9 cells alone were treated with CTZ, treatment of EM42 cells with 40 µM CTZ decreased EM42 attachment to LP9 cells by 27% (P < 0.01). Treatment of both EM42 and LP9 cells with 40 µM CTZ decreased EM42 attachment to LP9 by 37% (P < 0.01). Treatment of EM42 cells with 40 µM CTZ decreased attachment to HA by 66% (P = 0.056). CTZ did not decrease invasion of EM42 cells through the LP9 monolayer. CTZ may inhibit EM42 cell proliferation. In conclusion, CTZ significantly decreased EM42 attachment to LP9 cells and HA in an in vitro model of the early endometriotic lesion.
机译:这项研究的目的是研究在成熟的早期子宫内膜异位病变模型中,过氧化物酶体增殖物激活受体(PPAR)-γ激活是否对子宫内膜细胞与腹膜间皮细胞的附着有影响。子宫内膜上皮细胞系EM42和间皮细胞系LP9用于这项研究。用PPAR-γ激动剂西格列酮(CTZ)以不同的浓度(10、20和40 µM)×48小时处理EM42细胞,LP9细胞或两者,然后共同培养EM42和LP9细胞。然后评估EM42附着和通过LP9细胞侵袭的速率,并将其与对照(未经CTZ预先处理的EM42和LP9细胞共培养)进行比较。接下来,评估了经CTZ处理和未处理的EM42细胞与透明质酸(HA)的结合,透明质酸是腹膜间皮细胞上的一种细胞粘附分子(CAM)。尽管仅用CTZ处理LP9细胞时EM42附着没有差异,但用40 µM CTZ处理EM42细胞会使EM42与LP9细胞的附着降低27%(P <0.01)。用40 µM CTZ处理EM42和LP9细胞,可使EM42与LP9的附着降低37%(P <0.01)。用40 µM CTZ处理EM42细胞可使与HA的附着减少66%(P = 0.056)。 CTZ不会通过LP9单层减少EM42细胞的侵袭。 CTZ可能抑制EM42细胞增殖。总之,在早期子宫内膜异位病变模型中,CTZ显着降低了EM42对LP9细胞和HA的附着。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号